Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Medicare May Join Forces with Apple Watch to Monitor Consumer Health

Posted on May 1st, 2019 by in Pharma R&D

Istanbul, Turkey – September 6, 2015: A woman wearing 42mm stainless steel Apple Watch with white sports band. The Apple Watch became available April 24, 2015, bringing a new way to receive information at a glance, using apps designed specifically for the wrist.

Apple is a company that has long been thought of us an innovator that has brought consumers an array of enticing gadgets, from home computers to iPods to smartphones. This technology has been transformative for its users, but mostly it has been associated with work and play. Increasingly, though, Apple appears to be interested in getting involved in another critical part of our lives: our health.

(more…)

The Election 2016: A Scientist Reflects

Posted on November 15th, 2016 by in Pharma R&D

Like many of my science colleagues in the U.S., I was gobsmacked by the outcome of the presidential election last Tuesday. With some exceptions, most of my academic and industry colleagues were supporting the Clinton campaign in the general election. (more…)

2016 US Elections Fearful or Fertile Ground for Pharma?

Posted on November 10th, 2016 by in Pharma R&D

The elections outcome, the morning after, which is so fresh in everyone’s mind that we need to see how a Trump Presidency will shape the future growth of the US economy and in turn ultimately allow growth in innovation in Pharma Industry. (more…)

R&D Innovation & Pharma Drug-Device Pricing

Posted on September 26th, 2016 by in Pharma R&D

The media as of late has given a lot of coverage to the “price gouging” that pharmaceutical company Mylan engaged in with its injection device EpiPen. (more…)